Not recruiting
Parkinson's disease
Not recruitingInvestigational
Study of CVN424 for Reducing Motor Complications in Parkinson's Disease Patients
Investigational
- Disease:Parkinson's disease
- Substances:1-[2-[4-(2,4-DIFLUOROPHENOXY)PIPERIDIN-1-YL]-3-[[(3R)-OXOLAN-3-YL]AMINO]-7,8-DIHYDRO-5H-PYRIDO[3,4-B]PYRAZIN-6-YL]ETHANONE
Countries:
Czechia
Czechia- Participants:18–64 years · 65+ years
- Substances:1-[2-[4-(2,4-DIFLUOROPHENOXY)PIPERIDIN-1-YL]-3-[[(3R)-OXOLAN-3-YL]AMINO]-7,8-DIHYDRO-5H-PYRIDO[3,4-B]PYRAZIN-6-YL]ETHANONE
- Sponsor:Cerevance Beta Inc.



